FIR against five people filed by Maharashtra FDA for blackmarketing of remedisivir and tocilizumab

The Maharashtra Food and Drug Administration (FDA), along with Anti Extortion Cell (AEC), has filed the FIR for black marketing racket of remdisivir and tocilizumab drugs. The team also seized other therapeutic medicines worth Rs 3,13,482.

Viraj Paunikar, Joint Commissioner, Thane FDA, informed, “Two days back, an activist informed the Thane, Mumbai police about the black marketing of COVID-19 drugs within the vicinity. Based on the information, we put up a trap and arrested five people involved in selling Cipla’s cipremi (remdesivir) and actemra (tocilizumab) without a drug sale license; and we caught them red-handed selling remdesivir at Rs 25,000 (the company’s MRP of the said drug is Rs 4,000) and tocilizumab approximately at Rs 80,000, which are much higher than the market retail prices. All five of them are found guilty in violating different sections of the Indian Penal Code (IPC) like section 420, 34, etc., along with DPCO, essential commodities Act, Drugs and Cosmetic Rules/Act, etc. Hence, the local police have filed the first information report (FIR) against them,” informed Paunikar.

“From the initial investigation, the team realised that the master mind of this racket was Amitabh Das, a resident of Kalamboli, Raigad district. From his house, we have collected other medicines like anti-cancer drug, MTP kits, etc; and the team is investigating about the source of these medicines.” He further added
Jugalkishor B Mantri, Joint Commissioner, State Controller, Maharashtra and State Drug Controlling Authority of Mumbai, said that, “Together, local police administration and state FDA officers are working aggressively to bring down the unethical marketing practices in the state.”

“To address the issues related to the unavailability as well as black marketing of essential drugs in the state, we have recently launched the 24×7 control room at our Mumbai head office, and infact, we have got a lead of another black marketing of these medicines (remdesivir and tocilizumab) and we are working on that lead and hopefully in few days will be able to spot that racket too.” He further added.

  • Related Posts

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Boehringer Ingelheim launches AI centre for pharma research in London

    Boehringer Ingelheim launches AI centre for pharma research in London

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid